RPXIX
Price
$32.01
Change
+$0.07 (+0.22%)
Updated
Dec 3 closing price
Net Assets
51.16M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

RPXIX vs VIGRX

Header iconRPXIX vs VIGRX Comparison
Open Charts RPXIX vs VIGRXBanner chart's image
RiverPark Large Growth Institutional
Price$32.01
Change+$0.07 (+0.22%)
VolumeN/A
Net Assets51.16M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
RPXIX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
RPXIX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPXIX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. RPXIX (51.2M). VIGRX pays higher dividends than RPXIX: VIGRX (0.30) vs RPXIX (0.00). RPXIX was incepted earlier than VIGRX: RPXIX (15 years) vs VIGRX (33 years). RPXIX (1.02) is less costly to investors than VIGRX (0.17). RPXIX is a more actively managed with annual turnover of: 21.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than RPXIX: VIGRX (3000) vs RPXIX (50000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. RPXIX (2.56). VIGRX return over 5 years is better than : 99.11 vs. RPXIX (-1.44).
RPXIXVIGRXRPXIX / VIGRX
Total Expense Ratio1.000.17588%
Annual Report Gross Expense Ratio1.020.17600%
Fund Existence15 years33 years-
Gain YTD13.71219.76469%
Front LoadN/AN/A-
Min. Initial Investment5000030001,667%
Min. Initial Investment IRAN/AN/A-
Net Assets51.2M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year2.5618.4914%
Returns for 3 years82.93110.8275%
Returns for 5 years-1.4499.11-1%
Returns for 10 years74.52349.1321%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT